New Guideline Puts Some at the Front of the Line for GLP-1, SGLT2 Drugs

(MedPage Today) — No blanket recommendation can be made for SGLT2 inhibitors and GLP-1 receptor agonists in adults with type 2 diabetes (T2D) without considering cardiovascular and kidney risks, according to a BMJ panel.
In a new “living” guideline…

Source link : https://www.medpagetoday.com/endocrinology/diabetes/117003

Author :

Publish date : 2025-08-14 22:30:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

New Guideline Puts Some at the Front of the Line for GLP-1, SGLT2 Drugs

Weight Loss Before Military Training May Cut Injury Risk

Related Posts

Electroconvulsive Therapy Patients Often Not Fully Informed of Risks, Study Suggests

Weight Loss Before Military Training May Cut Injury Risk

BP Meds Should Begin Promptly, New ACC/AHA Guidelines Say

Are Wearable Health Trackers Really All That? Yes and No, Doctors Say

RFK Jr. Revives Dormant Vaccine Safety Task Force

Mousse Sunscreen Makers Get Warning From FDA

New Guideline Puts Some at the Front of the Line for GLP-1, SGLT2 Drugs

Electroconvulsive Therapy Patients Often Not Fully Informed of Risks, Study Suggests

Weight Loss Before Military Training May Cut Injury Risk

BP Meds Should Begin Promptly, New ACC/AHA Guidelines Say

Are Wearable Health Trackers Really All That? Yes and No, Doctors Say

RFK Jr. Revives Dormant Vaccine Safety Task Force

Mousse Sunscreen Makers Get Warning From FDA

Judge Orders HHS to Stop Sharing Medicaid Data With Deportation Officials

Categories

Archives